(CS-036) Clinical evaluation of a charged fiber based desloughing dressing on wounds at risk/with clinical signs of infection: results of a prospective, multicenter study in pediatric patients.

A large, prospective, multicentre, observational study was conducted on 2270 patients treated with the evaluated dressing. Main outcomes included the reduction of the number of infected wounds, the evolution of the clinical signs of local infection, wound healing rate, relative wound area reduction (RWAR), local tolerability, handling and acceptance of the dressing. The results presented here will focus on the outcomes achieved in paediatric patients.

Results:

A total 77 paediatric patients (2-17 years old) with wounds of various aetiologies were treated in 16 centres for a mean duration of 18±8 days. The wound infections and all the clinical signs of wound infection substantially reduced since the first visit (after 9±4 days of treatment) and throughout the treatment period. By the last visit, 86% of the wounds healed and 14% greatly improved (median RWAR of 75%). The dressing has been judged very easy to apply and very conformable, it was very well tolerated and accepted by both patients and healthcare professionals.

Discussion:

These results, documented in a cohort of 77 paediatric patients treated in current practice, comfort and complete the clinical evidence on the good healing properties and safety profile of the TLC-Ag dressing in the management of wounds at risk or with clinical signs of local infection.